Alkermes director Whitaker receives stock awards
Both awards are scheduled to vest in three equal annual installments beginning October 7, 2027.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Alkermes plc. director Anne Clem Whitaker received 7,239 restricted stock units and options covering 17,998 ordinary shares on October 7, 2026. Each restricted stock unit represents a contingent right to receive one ordinary share. The options have an exercise price of $41.4450 per share and expire October 7, 2036. Both awards vest in three equal annual installments beginning October 7, 2027.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Unit Award F1, F2 | 7,239 | $0.00 | $0.00 |
| Grant/Award | Non Qualified Stock Option (Right to Buy) F3 | 17,998 | $0.00 | $0.00 |
Footnotes (3)
- F1. Each restricted stock unit represents a contingent right to receive one ordinary share.
- F2. Shares subject to the restricted stock unit award vest in three equal annual installments commencing on 10/7/2027.
- F3. Shares subject to the stock option award vest in three equal annual installments commencing on 10/7/2027.
Key Figures
Key Terms
Restricted Stock Unit Award financial
Non Qualified Stock Option (Right to Buy) financial
contingent right financial
three equal annual installments financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What awards did ALKS director Anne Clem Whitaker receive?
What are the terms of Anne Clem Whitaker’s ALKS stock options?
AI-generated analysis. How Rhea-AI works. Not financial advice.